Type | Name | Gene Symbol | Clinical Significance | Chromosome | Start | Stop | Reference Allele | Alternate Allele | Review Status | Other IDs |
---|---|---|---|---|---|---|---|---|---|---|
(GRCh37) | ||||||||||
Deletion | NM_000059.4(BRCA2):c.4780del (p.Met1594fs) | BRCA2 | Pathogenic | 13 | 32913270 | 32913270 | GA | G | reviewed by expert panel | ClinGen:CA020827 |
Deletion | NM_000059.4(BRCA2):c.4797del (p.Asn1599fs) | BRCA2 | Pathogenic | 13 | 32913289 | 32913289 | AT | A | reviewed by expert panel | Breast Cancer Information Core (BIC) (BRCA2):5025&base_change=del T,ClinGen:CA020842 |
Deletion | NM_000059.4(BRCA2):c.4808del (p.Asn1603fs) | BRCA2 | Pathogenic | 13 | 32913296 | 32913296 | TA | T | reviewed by expert panel | ClinGen:CA020858 |
Duplication | NM_000059.4(BRCA2):c.4808dup (p.Asn1603fs) | BRCA2 | Pathogenic | 13 | 32913295 | 32913296 | T | TA | reviewed by expert panel | Breast Cancer Information Core (BIC) (BRCA2):5036&base_change=ins A,ClinGen:CA020855 |
Duplication | NM_000059.4(BRCA2):c.4828dup (p.Val1610fs) | BRCA2 | Pathogenic | 13 | 32913319 | 32913320 | T | TG | reviewed by expert panel | ClinGen:CA020877 |
Deletion | NM_000059.4(BRCA2):c.4848_4849del (p.Leu1616_Ser1617insTer) | BRCA2 | Pathogenic | 13 | 32913340 | 32913341 | TAA | T | reviewed by expert panel | ClinGen:CA020906 |
single nucleotide variant | NM_000059.4(BRCA2):c.4859T>G (p.Leu1620Ter) | BRCA2 | Pathogenic | 13 | 32913351 | 32913351 | T | G | reviewed by expert panel | ClinGen:CA020929 |
single nucleotide variant | NM_000059.4(BRCA2):c.4889C>A (p.Ser1630Ter) | BRCA2 | Pathogenic | 13 | 32913381 | 32913381 | C | A | reviewed by expert panel | ClinGen:CA020952 |
single nucleotide variant | NM_000059.4(BRCA2):c.4889C>G (p.Ser1630Ter) | BRCA2 | Pathogenic | 13 | 32913381 | 32913381 | C | G | reviewed by expert panel | ClinGen:CA020955 |
Deletion | NM_000059.4(BRCA2):c.488_489del (p.Ser163fs) | BRCA2 | Pathogenic | 13 | 32900391 | 32900392 | AGT | A | reviewed by expert panel | ClinGen:CA020947 |